Skip to content

An observation study of constipation and gut microbiota due to gastric acid suppressive drugs

An observation study of constipation and gut microbiota due to gastric acid suppressive drugs - Study of constipation and gut microbiota due to gastric acid suppressive drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028463
Enrollment
100
Registered
2017-08-01
Start date
2017-08-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation

Interventions

None listed

Sponsors

Kyoto Prefectural University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with early gastric cancer or superficial esophageal cancer who will receive PPI or PCAB for six weeks after endoscopic resection

Exclusion criteria

Exclusion criteria: Patients whom a researcher judged to be inappropriate as a subject Patients without written informed consent Patients with history of gastrectomy or esophagectomy Patients with intake of acid suppressive drugs before this study

Design outcomes

Primary

MeasureTime frame
Relation of constipation and gut microbiota after intake of acid suppressive drugs

Countries

Japan

Contacts

Public ContactOsamu Dohi

Kyoto Prefectural University of Medicine Department of Gastroenterology and Hepatology

osamu-d@koto.kpu-m.ac.jp075-251-5519

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026